A Placebo Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata (AA) Subjects
A Placebo Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata (AA) Subjects. A Phase 2b/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata
Category & Conditions: Immune System Diseases and Conditions
Medicine: PF-06651600
ClinicalTrials.gov Identifier (NCT): NCT03732807
Protocol ID: B7981015
PrintDownloadOpen Plain Language Summary Result: Click here